Coronavirus vaccine: India's new shot candidate can withstand 100 degrees C
New Delhi: The heat-tolerant Covid-19 vaccine candidate can be stored at 37 degrees Celsius for four weeks and at 100 degrees Celsius for up to 90 minutes.
Continue ReadingIn the Press
India’s ‘warm’ vaccine candidate effective against Delta, Omicron variants in mice: Study
New Delhi: A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.
Continue Reading
Work in progress: India-made ‘warm’ vaccine to fight COVID-19
New Delhi: The ‘warm’ vaccine developed by the Bengaluru-based Mynvax laboratories, a company incubated at the Indian Institute of Science Bangalore, is unique among existing vaccines in that it can be stored at 37 degree Celsius for four weeks and at 100 degree Celsius for upto 90 minutes.
Continue Reading
Australian researchers find Indian warm vaccine effective against Covid variants
New Delhi: The pandemic has rejuvenated Indian research — Covaxin produced by Bharat Biotech came out of the Indian Council of Medical Research (ICMR). And now, a new vaccine candidate from the Indian Institute of Science (IISc)’s spin-out Mynvax could be another game-changer.
Continue Reading
IISc-incubated Mynvax to raise $4.2mn to bring `warm vaccine’ to market
New Delhi: Mynvax, a vaccine technology startup, incubated by the Society for Innovation and Development (SID) at the Indian Institute of Science, on Monday said it has signed definitive agreements to raise $4.2 million ( ₹31 crores) in its Series A funding round led by Accel.
Continue Reading
Covid-19 study IISc’s Mynvax is effective against all major variants of concern: study
New Delhi: Mynvax, the “warm” Covid-19 vaccine developed by the researchers at the Indian Institute of Science (IISc), Bengaluru, is effective for all major variants of concern of SARS-CoV2 virus in animal studies.
Continue Reading
Mynvax’s “warm COVID-19 vaccine” is ready for safety tests and human clinical trials
Indian Institute of Science, Bangalore incubated Mynvax, which has published its study reporting its heat tolerant coronavirus vaccine candidate, is already in the stage for process development, manufacturing, formal safety and toxicity studies, and human clinical trials.
Continue Reading
The race to make a Covid-19 vaccine in India
In India, at least seven companies and research institutions are working on developing a vaccine candidate using different technological platforms and approaches.
Continue Reading